ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $19,408,000 | +4.3% | 292,735 | -1.7% | 2.24% | -3.1% |
| Q3 2021 | $18,599,000 | -24.1% | 297,915 | +0.6% | 2.31% | -54.3% |
| Q2 2021 | $24,517,000 | +24.9% | 296,024 | 0.0% | 5.06% | +2.6% |
| Q1 2021 | $19,629,000 | -15.1% | 296,024 | -0.9% | 4.93% | +14.3% |
| Q4 2020 | $23,127,000 | +47.3% | 298,687 | -18.1% | 4.32% | -14.3% |
| Q3 2020 | $15,701,000 | +410.6% | 364,636 | +412.1% | 5.04% | +379.1% |
| Q2 2020 | $3,075,000 | – | 71,199 | – | 1.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |